Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate in Bipolar I Disorder recurrence prevention
NCT01825837Phase 2Completed
- Sponsor
- BIAL
- Start
- Mar 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of eslicarbazepine acetate in bipolar I disorder, sponsored by BIAL. Started Mar 2006; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01825837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01825837.